2023
|
Invention
|
High-affinity t cell receptor targeting ny-eso-1 and use thereof. The present invention relates t... |
|
Invention
|
Antibody specifically binding to cd24 and use thereof. Provided are an anti-CD24 antibody or an a... |
2022
|
Invention
|
Antibody specifically binding to cd22, preparation method therefor and use thereof on bispecific ... |
|
Invention
|
Antibody specifically binding to cd22, and preparation method therefor and use thereof. The prese... |
|
Invention
|
Epitope peptide of ras g13d mutant and t cell receptor recognizing ras g13d mutant.
The present ... |
|
Invention
|
Epitope peptide of ras g13d mutant and t cell receptor recognizing ras g13d mutant. The present i... |
2021
|
Invention
|
T cell receptor for identifying ebv lmp2 antigen and use thereof. The present invention provides ... |
|
Invention
|
Ras mutant epitope peptide and t cell receptor recognizing ras mutant.
The present invention rel... |
|
Invention
|
Ras mutant epitope peptide and t cell receptor recognizing ras mutant. The present invention rela... |
|
Invention
|
Anti-cldn6 antibody and use thereof.
Provided are an anti-CLDN6 antibody or an antigen-binding f... |
|
Invention
|
Anti-cldn6 antibody and use thereof. Provided are an anti-CLDN6 antibody or an antigen-binding fr... |
|
Invention
|
Antibody specifically bound to glycosylated ceacam5. The present application provides an antibody... |
2020
|
Invention
|
Humanized anti-ceacam5 antibody, and preparation method therefor and use thereof. The present inv... |
|
Invention
|
Method for screening antibody binding to membrane protein based on cellular level. The present in... |
|
Invention
|
Anti-ceacam5 monoclonal antibody, preparation method thereof and use thereof.
Provided are a mon... |
|
Invention
|
Ceacam5-resistant monoclonal antibody and preparation method thereof and use thereof. Disclosed a... |
|
Invention
|
Anti-ceacam5 monoclonal antibody, preparation method therefor and use thereof. Provided are a mon... |
2019
|
Invention
|
Bcma-targeted antibody and chimeric antigen receptor.
An antibody specifically binding to BCMA a... |
|
Invention
|
Bcma-targeted antibody and chimeric antigen receptor. An antibody specifically binding to BCMA an... |
|
Invention
|
Compound having macrocyclic molecular structure and use thereof. The present disclosure relates t... |
2018
|
Invention
|
Anti-cldn18.2 antibody and uses thereof.
Provided are an anti-CLDN18.2 antibody or antigen-bindi... |
|
Invention
|
Anti-cldn18.2 antibody and uses thereof. Provided are an anti-CLDN18.2 antibody or an antigen bin... |
2016
|
Invention
|
Fully automated continuous cell culture system. The invention provides a full-automatic cell cult... |
|
Invention
|
Fully automated continuous cell culture system. Provided is a fully automated cell culture system... |